Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 325
Selected: 0
NCT IDTitle
NCT05704621Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT05549401Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT04627207A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers
NCT03858725Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
NCT06121518Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
NCT02753504Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT05452525Pharmacokinetics and Safety/Tolerability Profile of CKD-379
NCT03793985Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
NCT05108038A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04703374A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04075643Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
NCT03150316CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT01128322CKD-828 Primary Hypertension Trial(Dose-selection)
NCT01910077Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg
NCT06112678A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)
NCT01684605Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers
NCT06942156Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
NCT01842269Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients
NCT03051841CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT03063697Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
NCT05599152Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel
NCT03609606A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
NCT03601910Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg
NCT04805606A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
NCT02231788The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
NCT01746680Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis
NCT03762369A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT01019941Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer
NCT04660370A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
NCT05673369Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
NCT04258865A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
NCT03849261Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT04651881Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT02501200CKD-391 Pharmacokinetic Study Phase I
NCT07198191SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT02358824CKD-828 (80/5mg) Pharmacokinetic Study
NCT04673864A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
NCT02451098Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
NCT01580371Safety and Pharmacokinetic Profile of CKD-581
NCT03431623CKD-11101 Phase 3 SC Study
NCT03920579A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
NCT06110923A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
NCT01246193CKD-828(80/2.5mg) Pharmacokinetic Study
NCT04221360A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
NCT03627182Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
NCT02007941Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects
NCT05749861A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT01634295Efficacy and Safety of CKD-828 to Stage 2 Hypertension
NCT01029522Dyslipidemia in Cardiovascular Disease
NCT01106131Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin